申请人:Schering Corporation
公开号:EP1882686A2
公开(公告)日:2008-01-30
A NK1 antagonist having the formula (I), wherein Ar1 and Ar2 are optionally substituted phenyl or heteroaryl, X1 is an ether, thio or imino linkage, R4 and R5 are not both H or alkyl, and the remaining variables are as defined in the specification, useful for treating a number of disorders, including emesis, depression, anxiety and cough. Pharmaceutical compositions. Methods of treatment and combinations with other agents are also disclosed.
一种具有式(I)的 NK1 拮抗剂,其中 Ar1 和 Ar2 是任选取代的苯基或杂芳基,X1 是醚、硫或亚氨基连接,R4 和 R5 并非都是 H 或烷基,其余变量如说明书中所定义,可用于治疗多种疾病,包括呃逆、抑郁、焦虑和咳嗽。药物组合物。还公开了治疗方法和与其他制剂的组合。